Loading...
Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia
Inhibition of platelet production and mediated by antiplatelet antibodies is a well-known mechanism causing low platelet counts in immune thrombocytopenia (ITP). Use of thrombopoietin receptor agonists increases platelet counts and decreases the risk of bleeding in patients with ITP. Two such thromb...
Na minha lista:
| Udgivet i: | J Blood Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888762/ https://ncbi.nlm.nih.gov/pubmed/27307776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S80646 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|